Jeraldine Ortiz sabe que el cáncer de seno es difícil para las latinas. El cáncer de seno es la causa principal de muerte entre latinas. Esto se debe a las barreras culturales para la atención de salud, las bajas tasas de detección temprana y la baja participación en los estudios clínicos que buscan encontrar mejores tratamientos. Esta es la razón por la que Ortiz, cuando fue diagnosticada con cáncer de seno, decidió participar en un estudio clínico. Hoy, después de más de 15 años como sobreviviente de cáncer, Ortiz dijo que cree firmemente que su participación en un estudio clínico de UT Health San Antonio la ayudó a obtener un mejor tratamiento y una mejor calidad de vida después del cáncer. "Los estudios clínicos dan la oportunidad de un mejor ...
Hip hop artist Chuck D, one of the founding members of Public Enemy, once urged people of color to “Fight the Power.” Now he’s urging them to fight cancer. Chuck D wants people to “check your behind” and get screened for colon cancer as part of a new public service announcement (PSA) from Stand Up to Cancer / Unidos Contra El Cancer, a charitable fundraiser for cancer research. DJ and poet Pete Colon sings the same musical message in a Spanish-language PSA. In another PSA video, actress Uzo Abuda urges people of color to join clinical trials. “Hip-hop has a powerful voice and we’re using it to help make the community better, to try to get people to pay attention, to stay healthy and to catch things early instead of reading about it when it’s too late,” said ...
Breast cancer is the top cause of death for Latinas. But Alma Lopez has been a breast cancer survivor for more than 15 years. She believes participating in a clinical trial at UT Health San Antonio helped her get better treatment and better long-term health in her survivorship journey. “Clinical trials are great for finding new treatments that help people,” Lopez said. “And it helps the scientists. It gives opportunity to better medication for all populations. It builds a better future.”
Lopez Chooses a Breast Cancer Clinical Trial
About 15 years ago, Lopez was diagnosed with breast cancer. Lopez began weighing her treatment options. At first, she had doubts about whether to volunteer for a clinical trial. She thought it might take too much time, or cause ...
El cáncer de Seno es la causa principal de muerte en las latinas. Pero Alma López ha sido una sobreviviente de cáncer de seno por más de 15 años. Ella cree que su participación en un estudio clínico de UT Health San Antonio la ayudó a tener un mejor tratamiento y a largo plazo una mejor salud en su camino de supervivencia. "Los estudios clínicos pueden encontrar tratamientos nuevos que ayudan a las personas", dijo López. "Y ayudan a los científicos. Ofrecen la oportunidad de tratamientos mejores para todas las poblaciones. Construyen un futuro mejor".
López Decidió Participar en un Estudio Clínico de Cáncer de Seno
Aproximadamente hace 15 años, López fue diagnosticada con cáncer de seno. López comenzó a considerar sus opciones de tratamiento. Al ...
Simple logistics—availability, childcare, and time—stop some Latinas and other women of color from volunteering for breast cancer clinical trials, according to a new survey. The survey, led by For The Breast of Us, an online breast cancer survivor community, and Sommer Consulting, found that the anticipated time demands of a clinical trial may appear "too intimidating." Most women of color struggle with multiple demands in their lives. The perceived or real logistics of participating in a clinical trial could make it harder. One respondent said: “You still have to worry about how am I going to run my household, especially as a woman of color, who typically a lot of times are single-family or single-parent households." "The results of this survey demonstrate how ...
Are you Latino? Have you participated in a clinical trial related to cancer, Alzheimer’s, or another condition? If so, we want to talk with you and share your story! Salud America! is looking to interview and write stories about heroes like you — Latinos who have participated in a clinical trial — to showcase the benefits of volunteering to inspire other Latinos to volunteer, too. Dr. Amelie G. Ramirez’s Salud America! program at UT Health San Antonio is sharing the stories of clinical trial heroes with the support of Genentech, a member of the Roche Group. “Clinical trials are studies that help researchers learn more and more to help slow, manage, and treat Alzheimer's and cancer,” Ramirez said. “Clinical trials help us fight for our familia.” To share ...
Breast cancer is the leading cause of death in Latinas. Systemic health inequities contribute to lower rates of breast cancer screening among Latinos, which leads to cancer diagnoses at later disease stages. This is why we're sharing Susan G. Komen’s 2021 ongoing webinar series on metastatic breast cancer (MBC)! The next two webinars, "MBC in the Hispanic/Latino Community," are set for 6 p.m. CT Sept. 23, 2021, in English and 6 p.m. CT Sept. 30, 2021, in Spanish. Panelists are: Dr. Filipa Lynce, Dana-Farber Cancer Institute, Director, Inflammatory Breast Center, Harvard Medical School.
Dr. Jose Pablo Leone, Dana-Farber Cancer Institute, Director, Program for Breast Cancer in Men, Harvard Medical School Panelists will foster a safe, collaborative space to discuss ...
In the next 20 years, Latinos could face a 142% rise in cancer rates. Latinos also experience cancer differently—from genetics to healthcare access to survivorship. This is why Dr. Amelie Ramirez, director of Salud America! at UT Health San Antonio, is hosting the Advancing the Science of Cancer in Latinos 2022 conference on Feb. 23-25, 2022 in San Antonio! "Our vision is to unite researchers, physicians, healthcare professionals, patient advocates and students from across the nation to discuss research advancements, identify gaps, and create action to translate basic research into clinical best practices, effective community interventions, and professional training programs to eliminate cancer disparities in Latinos," said Ramirez, whose Institute for Health Promotion Research ...
El cáncer es un camino difícil, miedoso y peligroso para la vida, especialmente para las mujeres de color. Por esto es que los investigadores realizan estudios clínicos, que son estudios para encontrar tratamientos más efectivos o para lograr un mejor entendimiento del cáncer de seno y la supervivencia en las minorías. Pero, para progresar, los estudios clínicos necesitan voluntarios diversos, como Elsada Wilson. Wilson participó en un estudio clínico del Mays Cancer Center de UT Health San Antonio y encontró esperanza para ella, su familia y el futuro. "Sentí que estaba ayudando a avanzar los estudios y el conocimiento", dijo. "Si me ayuda, entonces podré ayudar a mi familia y ayudar a otras personas que necesitan ayuda. Quería ayudar a los demás. Me dije a mí ...
